Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment
The treatment of patients with pulmonary embolism (PE) has evolved substantially over the past few decades. Many…
Anticoagulants
-
Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment
The treatment of patients with pulmonary embolism (PE) has evolved substantially over the past few decades. Many... -
Not All DOACs Have Same GI-Bleeding Risk
Rivaroxaban is associated with higher rates of gastrointestinal bleeding compared with other direct oral anticoagulants (DOACs), regardless... -
A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about...
Not All DOACs Have Same GI-Bleeding Risk
Rivaroxaban is associated with higher rates of gastrointestinal bleeding compared with other direct oral anticoagulants (DOACs), regardless…
A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…
New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…
Should You Use Direct Oral Anticoagulants for Cancer-Associated VTE?
The Case A 73-year-old man currently undergoing chemotherapy for colon cancer presents to the emergency department with…
Five Tips for Managing Intracerebral Hemorrhage
It is critical to master the management of the patient with intracerebral hemorrhage (ICH) because hematoma expansion…
Get the Latest Update on Atrial Fibrillation
In the past decade, emergency department visits directly due to atrial fibrillation have increased by more than…
Examining New and Old Anticoagulants and Their Effects
It’s normal to feel nervous if you are treating a patient with a gastrointestinal bleed who is…